Contact
Tel: +86-187 0254 3408
Email: sales@zjzsbiotech.com

Recap in CPHI & PMEC China

2024/07/16

Zhengshuo Biotechnology in 2024 CPHI & PMEC China

The 22nd World Pharmaceutical Raw Materials China Exhibition and the 17th World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition (CPHI & PMEC China 2024) have come to a successful conclusion at the Shanghai New International Expo Center on June 21!

This exhibition has brought together the global pharmaceutical industry, continued to explore integration and innovation, and made positive contributions to optimizing the pharmaceutical ecosystem and opening up new heights for the development of the pharmaceutical industry.

In 2024, the exhibition will cover an area of over 220,000 square meters, covering 26 exhibition halls in the Shanghai New International Expo Center, setting a new record. During the three-day exhibition, 99,749 professional visitors from 135 countries and regions were welcomed, of which overseas visitors accounted for nearly 25%, an increase of 41.4% over 2023, the highest in history. At the exhibition site, Chinese and foreign merchants came in droves, and the trade boom was surging, participating in the grand event of the pharmaceutical industry.

Zhejiang Zhengshuo Biotechnology Co., Ltd took part in this exhibition as well and met with many friends from worldwide. This is a great platform to know each other, not only to display products, but also for better communication face by face.

Whats service do we provide? We undertakes various types of bio-enzyme catalysis, protein expression and purification technology development and chiral compound customization services. We currently has a complete bio-enzyme catalysis technology, protein expression and purification platform, and has developed nearly 100 bio-enzyme catalysis, protein expression and purification technologies for more than 30 customers. The developed technologies involve health food raw materials, cosmetic raw materials, APIs, pharmaceutical intermediates and other chiral compounds.